Typhoid Vaccine Market Report

Europe Typhoid Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Dec 01, 2019
  • PAGES：224
  • REPORT CODE：GMM400600
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Typhoid Vaccine market was valued at 0.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Typhoid Vaccine Market Segmentations:

    By Player:

    • Sanofi

    • Merck & Co Inc.

    • AstraZeneca.

    • Johnson & Johnson

    • GlaxoSmithKline plc

    • Merck & Co. Inc.

    By Type:

    • Ty21a

    • Vi capsular polysaccharide vaccine

    • Vi Conjugate (Vi-TT)

    • Vi Conjugate (Vi-REPA).

    By End-User:

    • Hospitals

    • Pharmacies

    • Clinics / Health Care Centers

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Typhoid Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Typhoid Vaccine Market Size and Growth Rate of Ty21a from 2014 to 2026

    • 1.3.2 Europe Typhoid Vaccine Market Size and Growth Rate of Vi capsular polysaccharide vaccine from 2014 to 2026

    • 1.3.3 Europe Typhoid Vaccine Market Size and Growth Rate of Vi Conjugate (Vi-TT) from 2014 to 2026

    • 1.3.4 Europe Typhoid Vaccine Market Size and Growth Rate of Vi Conjugate (Vi-REPA). from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Typhoid Vaccine Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.2 Europe Typhoid Vaccine Market Size and Growth Rate of Pharmacies from 2014 to 2026

    • 1.4.3 Europe Typhoid Vaccine Market Size and Growth Rate of Clinics / Health Care Centers from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Typhoid Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Typhoid Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Ty21a

      • 3.4.2 Market Size and Growth Rate of Vi capsular polysaccharide vaccine

      • 3.4.3 Market Size and Growth Rate of Vi Conjugate (Vi-TT)

      • 3.4.4 Market Size and Growth Rate of Vi Conjugate (Vi-REPA).

    4 Segmentation of Typhoid Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Typhoid Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Typhoid Vaccine for Hospitals

      • 4.4.2 Market Size and Growth Rate of Typhoid Vaccine for Pharmacies

      • 4.4.3 Market Size and Growth Rate of Typhoid Vaccine for Clinics / Health Care Centers

    5 Market Analysis by Major Regions

    • 5.1 Europe Typhoid Vaccine Production Analysis by Top Regions

    • 5.2 Europe Typhoid Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Typhoid Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Typhoid Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Typhoid Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Typhoid Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Typhoid Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Typhoid Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Typhoid Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Typhoid Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Typhoid Vaccine Landscape Analysis

    • 7.1 Germany Typhoid Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Typhoid Vaccine Landscape Analysis by Major End-Users

    8. UK Typhoid Vaccine Landscape Analysis

    • 8.1 UK Typhoid Vaccine Landscape Analysis by Major Types

    • 8.2 UK Typhoid Vaccine Landscape Analysis by Major End-Users

    9. France Typhoid Vaccine Landscape Analysis

    • 9.1 France Typhoid Vaccine Landscape Analysis by Major Types

    • 9.2 France Typhoid Vaccine Landscape Analysis by Major End-Users

    10. Italy Typhoid Vaccine Landscape Analysis

    • 10.1 Italy Typhoid Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Typhoid Vaccine Landscape Analysis by Major End-Users

    11. Spain Typhoid Vaccine Landscape Analysis

    • 11.1 Spain Typhoid Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Typhoid Vaccine Landscape Analysis by Major End-Users

    12. Poland Typhoid Vaccine Landscape Analysis

    • 12.1 Poland Typhoid Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Typhoid Vaccine Landscape Analysis by Major End-Users

    13. Russia Typhoid Vaccine Landscape Analysis

    • 13.1 Russia Typhoid Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Typhoid Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Typhoid Vaccine Landscape Analysis

    • 14.1 Switzerland Typhoid Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Typhoid Vaccine Landscape Analysis by Major End-Users

    15. Turkey Typhoid Vaccine Landscape Analysis

    • 15.1 Turkey Typhoid Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Typhoid Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Typhoid Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Typhoid Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Typhoid Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Typhoid Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Typhoid Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Typhoid Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Typhoid Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Typhoid Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Typhoid Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Typhoid Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Typhoid Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Sanofi

      • 19.1.1 Sanofi Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Merck & Co Inc.

      • 19.2.1 Merck & Co Inc. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 AstraZeneca.

      • 19.3.1 AstraZeneca. Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Johnson & Johnson

      • 19.4.1 Johnson & Johnson Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 GlaxoSmithKline plc

      • 19.5.1 GlaxoSmithKline plc Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Merck & Co. Inc.

      • 19.6.1 Merck & Co. Inc. Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    The List of Tables and Figures (Totals 87 Figures and 152 Tables)

    • Figure Product Picture

    • Figure Europe Typhoid Vaccine Market Size and Growth Rate of Ty21a from 2014 to 2026

    • Figure Europe Typhoid Vaccine Market Size and Growth Rate of Vi capsular polysaccharide vaccine from 2014 to 2026

    • Figure Europe Typhoid Vaccine Market Size and Growth Rate of Vi Conjugate (Vi-TT) from 2014 to 2026

    • Figure Europe Typhoid Vaccine Market Size and Growth Rate of Vi Conjugate (Vi-REPA). from 2014 to 2026

    • Figure Europe Typhoid Vaccine Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Europe Typhoid Vaccine Market Size and Growth Rate of Pharmacies from 2014 to 2026

    • Figure Europe Typhoid Vaccine Market Size and Growth Rate of Clinics / Health Care Centers from 2014 to 2026

    • Figure Germany Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Typhoid Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Typhoid Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Typhoid Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Typhoid Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Typhoid Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Ty21a

    • Figure Market Size and Growth Rate of Vi capsular polysaccharide vaccine

    • Figure Market Size and Growth Rate of Vi Conjugate (Vi-TT)

    • Figure Market Size and Growth Rate of Vi Conjugate (Vi-REPA).

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Typhoid Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Typhoid Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Pharmacies

    • Figure Market Size and Growth Rate of Clinics / Health Care Centers

    • Table Europe Typhoid Vaccine Production by Major Regions

    • Table Europe Typhoid Vaccine Production Share by Major Regions

    • Figure Europe Typhoid Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Typhoid Vaccine Consumption by Major Regions

    • Table Europe Typhoid Vaccine Consumption Share by Major Regions

    • Table Germany Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table France Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Typhoid Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Typhoid Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Typhoid Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Typhoid Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table UK Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table France Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Typhoid Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Typhoid Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Typhoid Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Typhoid Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Merck & Co Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc.

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc.

    • Figure Revenue and Market Share Analysis of Merck & Co Inc.

    • Table Product and Service Introduction of Merck & Co Inc.

    • Table Company Profile and Development Status of AstraZeneca.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca.

    • Figure Sales and Growth Rate Analysis of AstraZeneca.

    • Figure Revenue and Market Share Analysis of AstraZeneca.

    • Table Product and Service Introduction of AstraZeneca.

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of Merck & Co. Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co. Inc.

    • Figure Sales and Growth Rate Analysis of Merck & Co. Inc.

    • Figure Revenue and Market Share Analysis of Merck & Co. Inc.

    • Table Product and Service Introduction of Merck & Co. Inc.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US